参考文献/References:
[1] Huber CH, Goeber V, Berdat P, et al. Benefits of cardiac surgery in octogenarians—a postoperative quality of life assessment[J]. Eur J Cardiothorac Surg,2007,31(6): 1099-1105.
[2] Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?[J]. Eur Heart J,2005,26(24):2714-2720.
[3] Kvidal P, Bergström R, Hörte LG, et al. Observed and relative survival after aortic valve replacement[J]. J Am Coll Cardiol,2000,35(3):747-756.
[4] Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic surgery(EACTS)and the European Society of Cardiology(ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J]. EuroIntervention,2008,4(2):193-199.
[5] O'Sullivan CJ, Stortecky S, Buellesfeld L, et al. Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure[J]. Clin Res Cardiol,2014,103(4):259-274.
[6] Bauer F, Eltchaninoff H, Tron C, et al. Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis[J]. Circulation,2004,110(11):1473-1476.
[7] Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis[J]. J Am Coll Cardiol,2009,53(20):1883-1891.
[8] Bekeredjian R, Krumsdorf U, Chorianopoulos E, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age[J]. Am J Cardiol,2010,106(12):1777-1781.
[9] Schoenenberger AW, Stortecky S, Neumann S, et al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation(TAVI)[J]. Eur Heart J,2013,34(9):684-692.
[10] Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. The U.K. TAVI(United Kingdom Transcatheter Aortic Valve Implantation)Registry[J]. J Am Coll Cardiol,2011,58(20):2130-2138.
[11] Blackman DJ, Baxter PD, Gale CP, et al. Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry[J]. J Interv Cardiol,2014,27(1):86-95.
[12] Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients[J]. N Engl J Med,2011,364(23):2187-2198.
[13] Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement[J]. N Engl J Med,2012,366(18):1686-1695.
[14] Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial[J]. EuroIntervention,2012,8(3):383-389.
[15] Piazza N, Kalesan B, van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients[J]. JACC Cardiovasc Interv,2013,6(5):443-451.
[16] D'Errigo P, Barbanti M, Ranucci M, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis:results from an intermediate risk propensity-matched population of the Italian OBSERVANT study[J]. Int J Cardiol,2013,167(5):1945-1952.
[17] Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis(PARTNER 1): a randomised controlled trial[J].Lancet,2015,385(9986):2477-2484.
[18] Jabs A, Kilic T, Schnelle N, et al. Transcatheter aortic valve implantation and four-year follow up in a 99-year-old patient[J].J Heart Valve Dis,2013,22(2):261-264.
[19] Verouhis D, Yamasaki K, Ivert T, et al. Transcatheter aortic valve implantation is feasible and safe in nonagenarians[J]. J Am Geriatr Soc,2014,62(1):189-190.
[20] Buellesfeld L, Gerckens U, Erbel R, et al. Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation:results from the German multicenter registry[J]. J Invasive Cardiol,2012,24(10):531-536.
[21] Havakuk O, Finkelstein A, Steinvil A, et al. Comparison of outcomes in patients ≤ 85 versus > 85 years of age undergoing transcatheter aortic-valve implantation[J]. Am J Cardiol,2014,113(1):138-141.
[22] Yamamoto M, Meguro K, Mouillet G, et al. Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged ≥ 90 years versus < 90 years[J]. Am J Cardiol,2012,110(8):1156-1163.
[23] Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association[J]. Circulation,2014,129(3): e28-e292.
[24] Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome(SOURCE)Registry:A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve[J]. Circulation,2010,122(1):62-69.
[25] Poliacikova P, Cockburn J, de Belder A, et al. Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation—comparison of regimes[J]. J Invasive Cardiol,2013,25(10):544-548.
[26] Durand E, Blanchard D, Chassaing S, et al. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation[J]. Am J Cardiol,2014,113(2):355-360.
[27] Czerwińska-Jelonkiewicz K, Witkowski A, Dbrowski M, et al. Antithrombotic therapy—predictor of early and long-term bleeding complications after transcatheter aortic valve implantation[J]. Arch Med Sci,2013,9(6):1062-1070.
[28] Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial[J]. JAMA,2014,311(15):1503-1514.
[29] Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation:predictive factors,prognostic value,and comparison with surgical aortic valve replacement[J]. Eur Heart J,2013,31(7):865-874.
[30] Goebel N, Baumbach H, Ahad S, et al. Transcatheter aortic valve replacement: does kidney function affect outcome?[J]. Ann Thorac Surg,2013,96(2):507-512.
[31] Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients[J]. N Engl J Med,2012,366(18):1705-1715.
[32] Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis[J]. Circulation,2011,123(3):299-308.
[33] Colli A, Gallo M, Bernabeu E, et al. Aortic valve calcium scoring is a predictor of paravalvular aortic regurgitation after transcatheter aortic valve implantation[J]. Ann Cardiothorac Surg,2012,1(2):156-159.
[34] Khawaja MZ, Haworth P, Ghuran A, et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements[J]. J Am Coll Cardiol,2010,55(2):97-101.
相似文献/References:
[1]于海波,综述,梁延春,等.经导管主动脉瓣膜置换术后房室传导阻滞的预警[J].心血管病学进展,2016,(4):419.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.024]
YU Haibo,LIANG Yanchun.Predicting Factors of Atrioventricular Block after Transcatheter
Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2016,(6):419.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.024]
[2]于子凯 许海燕 刘庆荣 吴永健.合并常见疾病对经导管主动脉瓣置换术患者预后的影响[J].心血管病学进展,2019,(5):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
YU Zikai,XU Haiyan,LIU Qingrong,et al.Influence of ommon Accompanied Diseases on Prognosis of Patients after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2019,(6):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
[3]邵美华 周玉强 王萌萌 王宝珠 马翔.经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄研究进展[J].心血管病学进展,2020,(11):1184.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[4]夏平.“8+2”心电图临床价值的研究进展夏平[J].心血管病学进展,2021,(9):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
XIA Ping.Clinical Value of 8 Plus 2 ECG[J].Advances in Cardiovascular Diseases,2021,(6):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
[5]李宗泽 何贵均 郑晓菲 蒋晖 刘汉雄.经导管主动脉瓣置换术后合并心房颤动的抗栓策略[J].心血管病学进展,2021,(10):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
LI ZongzeHE GuijunZHENG XiaofeiJIANG HuiLIU Hanxiong.Optimal Antithrombotic Strategies after Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(6):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
[6]王卫卫 于子凯 吴永健 许海燕 刘庆荣.序贯综合心脏康复模式在经导管主动脉瓣置换术患者中应用现状[J].心血管病学进展,2022,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
WANG Weiwei,YU Zikai,WU YongjianXU HaiyanLIU Qingrong.The Status of Sequential Comprehensive Cardiac Rehabilitation in Patients?ndergoing Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(6):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
[7]张航 安景辉 石凤梧.极简式经导管主动脉瓣置换术的研究现状[J].心血管病学进展,2022,(9):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
ZHANG Hang,AN Jinghui,SHI Fengwu.Minimalist Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(6):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
[8]达尼亚尔·迪力木拉提 施林 严飞.二叶式主动脉瓣发病机制及其临床诊治的研究进展[J].心血管病学进展,2023,(5):412.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.007]
Daniyar·Dilmurat,SHI Lin,YAN Fei.The PathogenesisClinical Diagnosis and Treatment of Bicuspid Aortic Valve[J].Advances in Cardiovascular Diseases,2023,(6):412.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.007]